×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Press Release

GE Healthcare, Wayra UK to Support Startups to Develop AI Applications for Healthcare with New Accelerator Programme

December 17, 2020

The ‘Edison™ Accelerator’ Programme will give six healthcare start-ups access to world-class technical mentorship and business development support

London, UK – December 17, 2020 – GE Healthcare and Wayra UK announce today the launch of GE’s regional programme to support digital health start-ups to develop AI applications for healthcare and accelerate the path of new AI solutions for healthcare to market.

For media inquiries, please contact:

Jhanvi Gudka
Wayra
+44 7921 920622
[email protected]
Natalie Bishop
Wayra
+44 7785 766854
[email protected]
Delphine Benoit
Communications Director, EMEA
GE Healthcare
+33 6 29 30 00 74
[email protected]
Hannah Huntly
Director, External Communications
GE Healthcare
+44 7887 824201
[email protected]
business unit
Press Release

GE Healthcare Powers First-of-Its Kind Virtual ICU, Creating Access to Critical Care Specialists throughout State of Oregon

December 16, 2020
Press Release

GE Healthcare and St. Luke’s University Health Network Accelerate Breast Cancer Care with First One-Stop Clinic in the U.S.

December 14, 2020

 

  • St. Luke’s University Health Network in Pennsylvania to serve as national model for rapid diagnostic breast cancer centers
  • One-stop breast clinics worldwide have revolutionized patient outcomes, with same-day results for 75 percent of patients and 80 percent patient satisfaction at the flagship clinic[1]

 

business unit
Press Release

GE Healthcare Completes Portfolio of Macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) with U.S. FDA Approval of Clariscan in 5mL Glass Vials

December 10, 2020
  • The U.S. FDA has approved 5mL glass vial packaging for Clariscan (gadoterate meglumine), completing its packaging portfolio.
  • Clariscan is now approved for patients aged two years and under, making the 5mL vials an efficient option for helping to minimize potential contrast wastage with pediatric patients.
  • Clariscan has been approved in more than 70 countries globally, with more than seven million patient doses shipped.

Marlborough, US – December 10, 2020 – GE Healthcare has received U.S.

business unit
Press Release

A Better Patient Experience at SimonMed Imaging Coming with new GE MRI Tech

December 08, 2020

SCOTTSDALE, AZ – December 8, 2020 -- SimonMed Imaging, one of the largest outpatient imaging providers in the US, is pleased to be the first in Arizona to bring a new, patient-friendly MRI technology to patients.

For media inquiries, please contact:

Amanda Gintoft
GE Healthcare
4144127062
[email protected]
business unit
Press Release

GE Healthcare запускает первую программу обучения для врачей УЗИ в Международном медицинском кластере Сколково

December 07, 2020

МОСКВА, Россия, 7 декабря 2020 г. – GE Healthcare и Фонд международного медицинского кластера заключили соглашение о развитии сотрудничества в области образовательных инициатив для специалистов здравоохранения. Локализация глобальной экспертизы является частью стратегии GE Healthcare, последовательно реализуемой в России на протяжении многих лет, в том числе в партнерстве с лидерами медицинской индустрии.

business unit
Press Release

GE Healthcare Expands AI, Digital and Imaging Solutions at #RSNA20, Helping Shape Future of Healthcare in the COVID Era

November 29, 2020

CHICAGO – 29 NOVEMBER 2020 – GE Healthcare today unveiled a slate of new intelligently efficient solutions to help clinicians solve today’s two-part challenge of delivering high quality care while managing greater capacity and workflow issues, exacerbated by the impact of COVID-19.

For media inquiries, please contact:

Margaret Steinhafel
GE Healthcare
+1 608 381 8829
[email protected]
business unit
Press Release

GE Healthcare Announces U.S. FDA approval of macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) in Pre-Filled Syringes

November 24, 2020
Press Release

GE Healthcare Announces First X-ray AI to Help Assess Endotracheal Tube Placement for COVID-19 Patients

November 23, 2020

 

business unit
Press Release

GE Healthcare Pioneers Photon Counting CT with Prismatic Sensors Acquisition

November 20, 2020

GE Healthcare invests in a unique approach to cutting-edge CT technology and acquires Prismatic Sensors AB, a leader in Deep Silicon detector technology for photon counting computed tomography (PCCT)

For media inquiries, please contact:

Margaret Steinhafel
GE Healthcare
+1 608 381 8829
[email protected]
business unit
Subscribe to GE Healthcare